Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.
Thymic Neuroendocrine Tumors / Lausi, P. O.; Refai, M.; Filosso, P. L.; Ruffini, E.; Oliaro, A.; Guerrera, F.; Brunelli, A.. - In: THORACIC SURGERY CLINICS. - ISSN 1547-4127. - 24:3(2014), pp. 327-332. [10.1016/j.thorsurg.2014.05.007]
Thymic Neuroendocrine Tumors
Filosso P. L.;
2014
Abstract
Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.
| File | Dimensione | Formato | |
|---|---|---|---|
|
008_Thymic neuroendocrine tumors.pdf
Accesso riservato
Dimensione
687.5 kB
Formato
Adobe PDF
|
687.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
